Drugmakers Argue Carve-Out Case Before Supreme Court

Washington Drug Letter
A A
U.S. Supreme Court Justices sharply questioned drug industry attorneys Dec. 5 as the court prepares to define the FDA’s authority in accepting and challenging brand drugmakers’ patent use codes for products.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00